Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-08-22
2006-08-22
Tate, Christopher R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C426S656000, C530S378000
Reexamination Certificate
active
07094751
ABSTRACT:
The utility of soybeans having a composition of greater than 40% of the protein as beta-conglycinin and less than 10% of the protein as glycinin for making highly functional high beta-conglycinin compositions was discovered. The discovered ingredients are useful for mimicking the texturizing properties of casein while also maintaining or improving physiological benefits of soy protein ingredients (e.g., cholesterol and triglyceride lowering properties). The high stability of the high beta-conglycinin compositions against protein-protein aggregation reactions is valuable for creating good tasting beverages and beverage mixes. Cheese with good spreadability, gloss and smoothness was made using an enzyme-modified version of the new ingredient composition. Cheese with good firmness and meltability was also create using a different enzyme-treatment. High beta-conglycinin compositions were found to demonstrate excellent emulsifying and gelling properties in the pH region (5.5-6.2) relevant to meat applications. High beta-conglycinin compositions also have possible use for improving the composition of essential amino acids for infant human and animals.
REFERENCES:
patent: 3953611 (1976-04-01), Youngquist
patent: 4302473 (1981-11-01), Mikami et al.
patent: 4368151 (1983-01-01), Howard et al.
patent: 4409256 (1983-10-01), Johnson et al.
patent: 4771126 (1988-09-01), Hirotsuka et al.
patent: 5270200 (1993-12-01), Sun et al.
patent: 5443974 (1995-08-01), Hitz et al.
patent: 5603045 (1997-02-01), Dockser
patent: 5936140 (1999-08-01), Beach
patent: 6022700 (2000-02-01), Monks et al.
patent: 6171640 (2001-01-01), Bringe
patent: 6576820 (2003-06-01), Takaiwa et al.
patent: 6703544 (2004-03-01), Kinney et al.
patent: 6828491 (2004-12-01), Kinney et al.
patent: 2003/0041350 (2003-02-01), Kinney et al.
patent: 2005/0015826 (2005-01-01), Kinney et al.
patent: 2005/0164337 (2005-07-01), Duranti et al.
patent: 0072617 (1983-02-01), None
patent: 0501117 (1992-09-01), None
patent: 0522800 (1993-01-01), None
patent: 0797928 (1997-10-01), None
patent: 1443160 (1976-07-01), None
patent: 59109130 (1984-06-01), None
patent: 3143356 (1991-06-01), None
patent: 09075007 (1997-03-01), None
patent: WO 98/44807 (1998-10-01), None
D.E. Evans, et al., A small scale method for the production of soymilk and silken tofu, Crop Science, Sep.-Oct., 1997, vol. 37, No. 5, pp. 1463-1469.
Kazuhiro Yagasaki, Biochemical Characterization of Soybean Protein Consistin of Different Subunits of Glycinin, J. Agric. Food Chem., Mar. 1997, vol. 45, 656-660.
Marley Marico Utumi, et al., Effect of genetic elimination of lipoxygenases and storage protein subunits of soybean protein quality, Revista Brasileira de Fisologia Vegetal (1998), vol. 10, No. 3, pp. 203-212.
H. M. Chen, Structural analysis of antioxidative peptides from soybean beta-conglycinin, Journal of Agricultural and Food Chemistry, Mar. 1995, vol. 43, No. 3, pp. 574, 578 (Abstract only).
T. Matoba, et al., Mechanism of beany flavor formation in lipoxygenase-deficient soybean, Report of the Soy Protein Research Committee, 1996, vol. 17, pp. 29-32 (Abstract only).
A. Kobyashi, et al. Aroma constituents of soybean (Glycine ax (L.) Merril) milk lacking lipoxygenase isozymes, Journal of Agricultural and Food Chmistry, 1995, vol. 43, No. 9, pp. 2449-2452 (Abstract only).
Data base abstract. FEDRIP. Research Summary. Identifying No. 0174449, NEB-12-259, Assessment of Genetic Variation for End-Use Quality Traits in Soybean, University of Nebraska, 1997.
Domoroshchenkova et al., Data base abstract. AN: 93(10):G0032 FSTA.Proceedings of the World Conference on Oilseed Technology and Utilization, pp. 416-419, 1993.
Dreau et al., “Semi-quantitative purification and assessment of purity of three soybean proteins—glycinin, β-conglycinin and α-conglycinin—by SDS-PAGE electrophoresis, densitometry and immunoblottin,”J. Food Sci. Technol., 31:489-493, 1994.
Kitamura, “Breeding trial for improving the food-processing quality of soybeans,”Trends Food Sci.&Technol., 4:64-67, 1993.
Lee et al., Data base abstract. AN: 93(10):N00006 FSTA.Korean Journal of Crop Science, 38(1):15-22, 1993.
Manzoni et al., “Soybean protein products as regulators of liver low-density lipoprotein receptors. II. α-α1rich commercial soy concentrate and α1deficient mutant differently affect low-density lipoprotein receptor activation,”J. Agric. Food Chem., 46:2481-2484, 1998.
Nagano et al., “Dynamic viscoelastic study on the gelation of 7s globulin from soybeans,”J. Agric. Food Chem., 40:941-944, 1992.
Nagano et al., “Dynamic viscoelastic study on the gelation properties of β-conglycinin-rich and glycinin-rich soybean protein isolates,”J. Agric. Food Chem., 44:3484-3488, 1996.
Patent Abstracts of Japan. Abs. Grp. No. C410, 11(85): for JP Appl. 60-77257. Inventors: Hirotsuka et al., 1987.
Saito et al., Data base abstract. AN: 70(05): J0456 FSTA.Agriculture and Biological Chemistry, 33(9):1301-1308, 1969.
Sykes et al., “Detection and characterization of a new beta-conglycinin from soybean seeds,”Archived of Biochemistry and Biophysics, 210:525-530, 1981.
Yagasaki et al., “Biochemical characterization of soybean protein consisting of different subunits of glycinin,”J. Agric. Food Chem., 45:656-660, 1997.
Yao et al., “Effects of maturation and storage on solubility, emulsion stability and gelatin properties of isolated soy proteins,”JAOCS, 67:974-979, 1990.
Horisberger et al., “Ultrastructural localization of glycinin and β-conglycinin in glycine max (soybean) cv. Maple Arrow by the immunogold method,”Histochemistry, 85:291-294, 1986.
Ogawa et al., “α-subunit of β-conglycinin, an allergnic protein recognized by ige antibodies of soybean-sensitive patients with atopic dermtitis,”Biosci. Biotech. Biochem, 59:831-833, 1995.
Samoto et al., “Specific binding of allergenic soybean protein bly m bd 30k with χ and χ-subunits of conglycinin in soy milk,”Biosci. Biotech. Biochem, 60:1006-1010, 1996.
Samoto et al., “Substantially complete removal of the 34 kDa allergenic soybean protein, gly m bd 30 k, from soy milk of a mutant lacking the α-and α′-subunits of conglycinin,”Biosci. Biotech. Biochem, 60:1911-1913, 1996.
Samoto et al., “Substantially complete removal of three major allergenic soybean proteins (bly m bd 30k, gly m bd 28k, and the α-subunit of conglycinin) from soy protein by using a mutant soybean, tohoku 124,”Biosci. Biotech. Biochem, 61:2148-2150, 1997.
Utsumi et al., “Molecular design of soybean glycinins with enhanced food qualities and development of crops producing such glycinins,”Food Proteins and Lipids, 1997.
Fulbright & Jaworski L.L.P.
Harle Jennifer
Monsanto Corporation
Tate Christopher R.
LandOfFree
High beta-conglycinin products and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with High beta-conglycinin products and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and High beta-conglycinin products and their use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3656172